Weng CY - Search Results

1

Suppression of breast cancer cells resistant to a pure anti-estrogen with CAR-transduced natural killer cells.

Lin YZ, Lee CC, Cho DY, Wang YL, Chen CY, Weng CY, Chiu SC, Hung MC, Wang SC. Lin YZ, et al. Among authors: weng cy. Am J Cancer Res. 2021 Sep 15;11(9):4455-4469. eCollection 2021. Am J Cancer Res. 2021. PMID: 34659898 Free PMC article.

2

Loss of tyrosine 211 phosphorylation of proliferating cell nuclear antigen (PCNA) enhances postnatal mammary gland development.

Shen YC, Lin YZ, Wu WR, Lin PL, Liao CC, Chung FC, Chen CY, Weng CY, Wang SC. Shen YC, et al. Among authors: weng cy. Biomedicine (Taipei). 2024 Sep 1;14(3):40-48. doi: 10.37796/2211-8039.1462. eCollection 2024. Biomedicine (Taipei). 2024. PMID: 39386182 Free PMC article.

3

Signal transducer and activator of transcription 3 as molecular therapy for non-small-cell lung cancer.

Wang CY, Chao TT, Tai WT, Chang FY, Su WP, Chen YL, Chen PT, Weng CY, Yuan A, Shiau CW, Yu CJ, Chen KF. Wang CY, et al. Among authors: weng cy. J Thorac Oncol. 2014 Apr;9(4):488-96. doi: 10.1097/JTO.0000000000000107. J Thorac Oncol. 2014. PMID: 24736071 Free article.

4

Disease Activity Criteria Impact Dosing Interval Assignment in nAMD Trials.

Zarbin MA, Weng CY, London NJS, Koh AHC, Gallego-Pinazo R, Chaudhary V, Souverain A, Stoilov I, Margaron P. Zarbin MA, et al. Among authors: weng cy. Ophthalmol Retina. 2024 Dec 27:S2468-6530(24)00617-1. doi: 10.1016/j.oret.2024.12.021. Online ahead of print. Ophthalmol Retina. 2024. PMID: 39733838 Free article. No abstract available.

5

Demographics of Ophthalmology and Optometry Practices and Changes in Utilization Patterns of Procedures and Services Following Private Equity Acquisition.

Del Piero J, Yennam S, Mukhopadhyay A, Chen EM, Weng CY, Parikh R. Del Piero J, et al. Among authors: weng cy. Int Ophthalmol Clin. 2025 Jan 1;65(1):91-97. doi: 10.1097/IIO.0000000000000554. Epub 2024 Dec 23. Int Ophthalmol Clin. 2025. PMID: 39710911

6

Visual and Anatomic Outcomes From Ultracomplex Retinal Detachment Repair in a Large County Hospital.

Chen A, Coffee RE, Date RC, Weng CY. Chen A, et al. Among authors: weng cy. Int Ophthalmol Clin. 2025 Jan 1;65(1):69-73. doi: 10.1097/IIO.0000000000000545. Epub 2024 Dec 23. Int Ophthalmol Clin. 2025. PMID: 39710908

7

Photobiomodulation Therapy for Non-exudative Age-related Macular Degeneration.

Rodriguez DA, Song A, Bhatnagar A, Weng CY. Rodriguez DA, et al. Among authors: weng cy. Int Ophthalmol Clin. 2025 Jan 1;65(1):47-52. doi: 10.1097/IIO.0000000000000543. Epub 2024 Dec 23. Int Ophthalmol Clin. 2025. PMID: 39710905 Review.

8

Use of Home Optical Coherence Tomography for Retinal Diseases.

Bordbar DD, Bhatnagar A, Weng CY. Bordbar DD, et al. Among authors: weng cy. Int Ophthalmol Clin. 2025 Jan 1;65(1):41-46. doi: 10.1097/IIO.0000000000000546. Epub 2024 Dec 23. Int Ophthalmol Clin. 2025. PMID: 39710904 Review.

9

Follow-up Adherence After Teleretinal Screening for Diabetic Retinopathy.

Chamberlain PD, Date RC, Shen KL, Campagna GA, Piller LB, Chu YI, Weng CY. Chamberlain PD, et al. Among authors: weng cy. Int Ophthalmol Clin. 2025 Jan 1;65(1):35-39. doi: 10.1097/IIO.0000000000000540. Epub 2024 Dec 23. Int Ophthalmol Clin. 2025. PMID: 39710903

10

Comparing Teleretinal Screening-Identified Diabetic Retinopathy With Diabetic Nephropathy and Other Markers of Systemic Disease.

Rodriguez SM, Hamill EB, Sundaresan A, Guffey D, Weng CY. Rodriguez SM, et al. Among authors: weng cy. Int Ophthalmol Clin. 2025 Jan 1;65(1):27-33. doi: 10.1097/IIO.0000000000000544. Epub 2024 Dec 23. Int Ophthalmol Clin. 2025. PMID: 39710902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters